Article: Safety limit of large-volume hepatic radiofrequency ablation in a rat model

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleSafety limit of large-volume hepatic radiofrequency ablation in a rat model
AuthorsNg, KK1
Lam, CM1
Poon, RT1
Shek, TW1
Ho, DW1
Fan, ST1
Issue Date2006
PublisherAmerican Medical Association. The Journal's web site is located at http://www.archsurg.com
CitationArchives Of Surgery, 2006, v. 141 n. 3, p. 252-258 [How to Cite?]
DOI: http://dx.doi.org/10.1001/archsurg.141.3.252
AbstractBackground: Large-volume hepatic radiofrequency ablation (RFA) has been used to treat large liver tumors, but its safety limit is unknown. This study aimed to investigate the possible systemic responses of large-volume hepatic RFA and to estimate its safety limit in normal and cirrhotic rats. Hypothesis: Large-volume hepatic RFA causes a significant systemic inflammatory reaction. Design: Experimental study. Setting: University teaching hospital. Intervention: Using the Cool-tip RF System (Radionics, Burlington, Mass), RFA was performed for different percentages of the liver volume by weight in normal and cirrhotic Sprague-Dawley rats. Main Outcome Measures: Changes in concentrations of serum inflammatory markers (tumor necrosis factor α [TNF-α] and interleukin [IL] 6), functions of various end organs, and survival rates were assessed. Results: In the normal liver groups, the concentrations of TNF-α and IL-6 were significantly elevated in the early postoperative period when 50% (mean ± SD TNF-α concentration, 130.3 ± 15.6 pg/mL; mean ± SD IL-6 concentration, 163.2 ± 12.2 pg/mL) and 60% (mean ± SD TNF-α concentration, 145.7 ± 13.0 pg/mL; mean ± SD IL-6 concentration, 180.8 ± 11.0 pg/mL) of the liver volume were ablated compared with the control group (mean ± SD TNF-α concentration, 30.4 ± 9.9 pg/mL, P < .001; mean ± SD IL-6 concentration, 28.4 ± 6.7 pg/mL, P < .001). The concentrations of TNF-α and IL-6 in other groups remained similar to those in the control group. Thrombocytopenia, prolonged clotting time, and interstitial pneumonitis occurred when 50% and 60% of the liver volume were ablated. The 4-week survival rates were 100%, 60%, and 0% when 40%, 50%, and 60%, respectively, of the liver volume were ablated. Similar systemic inflammatory responses and poor survival rates were observed among the cirrhotic liver groups when 30% and 40% of the liver volume were ablated. Conclusions: The normal rats can tolerate RFA of 40% of the liver volume with minimal morbidity and no mortality whereas the cirrhotic rats can only tolerate 20% of the ablated liver volume. Beyond that limit, RFA would cause significant systemic inflammatory responses and poor survival. ©2006 American Medical Association. All rights reserved.
ISSN0004-0010
2011 Impact Factor: 4.239
2011 SCImago Journal Rankings: 0.301
DOIhttp://dx.doi.org/10.1001/archsurg.141.3.252
ISI Accession Number IDWOS:000235844800005
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorNg, KK
dc.contributor.authorLam, CM
dc.contributor.authorPoon, RT
dc.contributor.authorShek, TW
dc.contributor.authorHo, DW
dc.contributor.authorFan, ST
dc.date.accessioned2010-09-06T08:46:48Z
dc.date.available2010-09-06T08:46:48Z
dc.date.issued2006
dc.description.abstractBackground: Large-volume hepatic radiofrequency ablation (RFA) has been used to treat large liver tumors, but its safety limit is unknown. This study aimed to investigate the possible systemic responses of large-volume hepatic RFA and to estimate its safety limit in normal and cirrhotic rats. Hypothesis: Large-volume hepatic RFA causes a significant systemic inflammatory reaction. Design: Experimental study. Setting: University teaching hospital. Intervention: Using the Cool-tip RF System (Radionics, Burlington, Mass), RFA was performed for different percentages of the liver volume by weight in normal and cirrhotic Sprague-Dawley rats. Main Outcome Measures: Changes in concentrations of serum inflammatory markers (tumor necrosis factor α [TNF-α] and interleukin [IL] 6), functions of various end organs, and survival rates were assessed. Results: In the normal liver groups, the concentrations of TNF-α and IL-6 were significantly elevated in the early postoperative period when 50% (mean ± SD TNF-α concentration, 130.3 ± 15.6 pg/mL; mean ± SD IL-6 concentration, 163.2 ± 12.2 pg/mL) and 60% (mean ± SD TNF-α concentration, 145.7 ± 13.0 pg/mL; mean ± SD IL-6 concentration, 180.8 ± 11.0 pg/mL) of the liver volume were ablated compared with the control group (mean ± SD TNF-α concentration, 30.4 ± 9.9 pg/mL, P < .001; mean ± SD IL-6 concentration, 28.4 ± 6.7 pg/mL, P < .001). The concentrations of TNF-α and IL-6 in other groups remained similar to those in the control group. Thrombocytopenia, prolonged clotting time, and interstitial pneumonitis occurred when 50% and 60% of the liver volume were ablated. The 4-week survival rates were 100%, 60%, and 0% when 40%, 50%, and 60%, respectively, of the liver volume were ablated. Similar systemic inflammatory responses and poor survival rates were observed among the cirrhotic liver groups when 30% and 40% of the liver volume were ablated. Conclusions: The normal rats can tolerate RFA of 40% of the liver volume with minimal morbidity and no mortality whereas the cirrhotic rats can only tolerate 20% of the ablated liver volume. Beyond that limit, RFA would cause significant systemic inflammatory responses and poor survival. ©2006 American Medical Association. All rights reserved.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationArchives Of Surgery, 2006, v. 141 n. 3, p. 252-258 [How to Cite?]
DOI: http://dx.doi.org/10.1001/archsurg.141.3.252
dc.identifier.doihttp://dx.doi.org/10.1001/archsurg.141.3.252
dc.identifier.epage258
dc.identifier.hkuros116878
dc.identifier.isiWOS:000235844800005
dc.identifier.issn0004-0010
2011 Impact Factor: 4.239
2011 SCImago Journal Rankings: 0.301
dc.identifier.issue3
dc.identifier.openurl
dc.identifier.pmid16549690
dc.identifier.scopuseid_2-s2.0-33645102297
dc.identifier.spage252
dc.identifier.urihttp://hdl.handle.net/10722/83921
dc.identifier.volume141
dc.languageeng
dc.publisherAmerican Medical Association. The Journal's web site is located at http://www.archsurg.com
dc.publisher.placeUnited States
dc.relation.ispartofArchives of Surgery
dc.relation.referencesReferences in Scopus
dc.titleSafety limit of large-volume hepatic radiofrequency ablation in a rat model
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong